Table of Contents Europe Neurotherapeutic Drugs Market Report 2012-2023 1 Neurotherapeutic Drugs Overview 1.1 Product Overview and Scope of Neurotherapeutic Drugs 1.2 Classification of Neurotherapeutic Drugs by Product Category 1.2.1 Europe Neurotherapeutic Drugs Sales (K Units) Comparison by Types (2012-2023) 1.2.2 Europe Neurotherapeutic Drugs Sales (K Units) Market Share by Types in 2017 1.2.3 Peripheral Nervous System Disorders (PNS) Disorder 1.2.4 Autonomous Nervous System (ANS) Disorder 1.2.5 Central Nervous System (CNS) Disorders 1.2.6 Other 1.3 Europe Neurotherapeutic Drugs Market by Application/End Users 1.3.1 Europe Neurotherapeutic Drugs (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Hosptical 1.3.3 Drug Stores 1.3.4 Other 1.4 Europe Neurotherapeutic Drugs Market by Region 1.4.1 Europe Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 Germany Status and Prospect (2012-2023) 1.4.3 UK Status and Prospect (2012-2023) 1.4.4 France Status and Prospect (2012-2023) 1.4.5 Russia Status and Prospect (2012-2023) 1.4.6 Benelux Status and Prospect (2012-2023) 1.4.7 Italy Status and Prospect (2012-2023) 1.4.8 Spain Status and Prospect (2012-2023) 1.5 Europe Sales and Revenue ofSales and Revenue of Neurotherapeutic Drugs (2012-2023) 1.5.1 Europe Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) 1.5.2 Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Neurotherapeutic Drugs 2.2 Raw Material Analysis of Neurotherapeutic Drugs 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Neurotherapeutic Drugs 2.4 Other Costs Analysis of Neurotherapeutic Drugs 2.5 Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs 2.6 Manufacturing Process Analysis of Neurotherapeutic Drugs 2.7 Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers in 2018 2.8 Downstream Buyers 3 Europe Neurotherapeutic Drugs Players/Suppliers Profiles and Sales Data 3.1 Abbott 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Abbott Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Abbott Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.2 BD 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 BD Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 BD Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.3 Novartis AG 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Novartis AG Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Novartis AG Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.4 Johnson & Johnson 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Johnson & Johnson Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Johnson & Johnson Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.5 Pfizer 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 Pfizer Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 Pfizer Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.6 Sanofi-Aventis 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 Sanofi-Aventis Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 Sanofi-Aventis Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.7 Biogen 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Biogen Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Biogen Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.8 GlaxoSmithKline 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 GlaxoSmithKline Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 GlaxoSmithKline Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 3.9 AstraZeneca Merck 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Neurotherapeutic Drugs Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 AstraZeneca Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 AstraZeneca Merck Different Types of Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 AstraZeneca Merck Neurotherapeutic Drugs Volume in Different Applications and Its Application Share 4 Europe Neurotherapeutic Drugs Competition by Players/Manufacturers, Region, Type and Application 4.1 Europe Neurotherapeutic Drugs Market Competition by Players/Manufacturers 4.1.1 Europe Neurotherapeutic Drugs Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 Europe Neurotherapeutic Drugs Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 Europe Neurotherapeutic Drugs Sales and Revenue by Type 4.2.1 Europe Neurotherapeutic Drugs Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 Europe Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 Europe Neurotherapeutic Drugs Sales and Revenue by Application 4.3.1 Europe Neurotherapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 Europe Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 Europe Neurotherapeutic Drugs Sales (K Units) by Application 5 Germany Neurotherapeutic Drugs (Sales, Revenue and Price) 5.1 Germany Neurotherapeutic Drugs Sales and Value (2012-2017) 5.1.1 Germany Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 5.1.2 Germany Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 5.1.3 Germany Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 5.2 Germany Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 5.3 Germany Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 6 UK Neurotherapeutic Drugs (Sales, Revenue and Price) 6.1 UK Neurotherapeutic Drugs Sales and Value (2012-2017) 6.1.1 UK Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 6.1.2 UK Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 6.1.3 UK Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 6.2 UK Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 6.3 UK Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 7 France Neurotherapeutic Drugs (Sales, Revenue and Price) 7.1 France Neurotherapeutic Drugs Sales and Value (2012-2017) 7.1.1 France Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 7.1.2 France Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 7.1.3 France Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 7.2 France Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 7.3 France Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 8 Russia Neurotherapeutic Drugs (Sales, Revenue and Price) 8.1 Russia Neurotherapeutic Drugs Sales and Value (2012-2017) 8.1.1 Russia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Russia Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 8.1.3 Russia Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 8.2 Russia Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 8.3 Russia Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 9 Benelux Neurotherapeutic Drugs (Sales, Revenue and Price) 9.1 Benelux Neurotherapeutic Drugs Sales and Value (2012-2017) 9.1.1 Benelux Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 9.1.2 Benelux Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 9.1.3 Benelux Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 9.2 Benelux Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 9.3 Benelux Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 10 Italy Neurotherapeutic Drugs (Sales, Revenue and Price) 10.1 Italy Neurotherapeutic Drugs Sales and Value (2012-2017) 10.1.1 Italy Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Italy Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 10.1.3 Italy Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 10.2 Italy Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 10.3 Italy Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 11 Spain Neurotherapeutic Drugs (Sales, Revenue and Price) 11.1 Spain Neurotherapeutic Drugs Sales and Value (2012-2017) 11.1.1 Spain Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Spain Neurotherapeutic Drugs Revenue and Growth Rate (2012-2017) 11.1.3 Spain Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) 11.2 Spain Neurotherapeutic Drugs Sales (K Units) and Market Share by Type 11.3 Spain Neurotherapeutic Drugs Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 Europe Neurotherapeutic Drugs Market Forecast (2018-2023) 13.1 Europe Neurotherapeutic Drugs Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 Europe Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 Europe Neurotherapeutic Drugs Revenue and Growth Rate Forecast (2018-2023) 13.1.3 Europe Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) 13.2 Europe Neurotherapeutic Drugs Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 Europe Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 Europe Neurotherapeutic Drugs Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 Germany Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 UK Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 France Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Russia Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 France Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Italy Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Spain Neurotherapeutic Drugs Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 Europe Neurotherapeutic Drugs Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 Europe Neurotherapeutic Drugs Sales Forecast by Type (2018-2023) 13.3.2 Europe Neurotherapeutic Drugs Revenue Forecast by Type (2018-2023) 13.3.3 Europe Neurotherapeutic Drugs Price Forecast by Type (2018-2023) 13.4 Europe Neurotherapeutic Drugs Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure Europe Market Size (Million USD) Comparison 2012-2023 Table Europe Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Table Europe Neurotherapeutic Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table Europe Neurotherapeutic Drugs Sales (K Units) by Application (2016-2023) Figure Product Picture of Neurotherapeutic Drugs Table Europe Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure Europe Neurotherapeutic Drugs Sales (K Units) Market Share by Types in 2017 Figure Peripheral Nervous System Disorders (PNS) Disorder Picture Figure Autonomous Nervous System (ANS) Disorder Picture Figure Central Nervous System (CNS) Disorders Picture Table Europe Neurotherapeutic Drugs Sales (K Units) Comparison by Applications (2012-2023) Figure Europe Sales Market Share of Neurotherapeutic Drugs by Applications in 2017 Figure Hosptical Picture Figure Drug Stores Picture Figure Other Picture Table Europe Market Neurotherapeutic Drugs Revenue (Million USD) Comparison by Regions 2012-2023 Figure Germany Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure UK Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure France Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Russia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Benelux Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Italy Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Spain Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure Europe Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2023) Figure Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Neurotherapeutic Drugs Table Industry News List of Neurotherapeutic Drugs Figure Industry Chain Structure of Neurotherapeutic Drugs Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Neurotherapeutic Drugs in 2017 Figure Manufacturing Process Analysis of Neurotherapeutic Drugs Table Raw Materials Sources of Neurotherapeutic Drugs Major Manufacturers Europe Table Major Buyers of Neurotherapeutic Drugs Table Abbott Basic Information List Table Abbott Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Abbott Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Abbott Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Abbott Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Abbott Neurotherapeutic Drugs Volume in Other and Its Application Share Table BD Basic Information List Table BD Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure BD Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure BD Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure BD Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table BD Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table BD Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table BD Neurotherapeutic Drugs Volume in Other and Its Application Share Table Novartis AG Basic Information List Table Novartis AG Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Novartis AG Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis AG Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Novartis AG Neurotherapeutic Drugs Volume in Other and Its Application Share Table Johnson & Johnson Basic Information List Table Johnson & Johnson Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Johnson & Johnson Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson & Johnson Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Johnson & Johnson Neurotherapeutic Drugs Volume in Other and Its Application Share Table Pfizer Basic Information List Table Pfizer Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Pfizer Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Pfizer Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Pfizer Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Pfizer Neurotherapeutic Drugs Volume in Other and Its Application Share Table Sanofi-Aventis Basic Information List Table Sanofi-Aventis Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Sanofi-Aventis Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Sanofi-Aventis Neurotherapeutic Drugs Volume in Other and Its Application Share Table Biogen Basic Information List Table Biogen Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Biogen Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Biogen Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Biogen Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Biogen Neurotherapeutic Drugs Volume in Other and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure GlaxoSmithKline Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table GlaxoSmithKline Neurotherapeutic Drugs Volume in Other and Its Application Share Table AstraZeneca Merck Basic Information List Table AstraZeneca Merck Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure AstraZeneca Merck Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure AstraZeneca Merck Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure AstraZeneca Merck Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table AstraZeneca Merck Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table AstraZeneca Merck Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table AstraZeneca Merck Neurotherapeutic Drugs Volume in Other and Its Application Share Table Company Basic Information List Table Company Neurotherapeutic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company Neurotherapeutic Drugs Sales Growth Rate (2012-2017) Figure Company Neurotherapeutic Drugs Sales Europe Market Share (%) (2012-2017) Figure Company Neurotherapeutic Drugs Revenue Europe Market Share (%) (2012-2017) Table Peripheral Nervous System Disorders (PNS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Autonomous Nervous System (ANS) Disorder Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Central Nervous System (CNS) Disorders Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company Neurotherapeutic Drugs Volume in Hosptical and Its Application Share Table Company Neurotherapeutic Drugs Volume in Drug Stores and Its Application Share Table Company Neurotherapeutic Drugs Volume in Other and Its Application Share Table Europe Neurotherapeutic Drugs Sales (K Units) by Players/Manufacturers (2012-2017) Table Europe Neurotherapeutic Drugs Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 Europe Neurotherapeutic Drugs Sales Market Share (%) by Players/Manufacturers Figure 2017 Europe Neurotherapeutic Drugs Sales Share by Players/Manufacturers Table Europe Neurotherapeutic Drugs Revenue (Million USD) by Players/Manufacturers (2012-2017) Table Europe Neurotherapeutic Drugs Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 Europe Neurotherapeutic Drugs Revenue Market Share (%) Players Figure 2017 Europe Neurotherapeutic Drugs Revenue Market Share (%) Players Table Europe Neurotherapeutic Drugs Sales (K Units) and Market Share (%) by Type (2012-2017) Table Europe Neurotherapeutic Drugs Sales Share by Type (2012-2017) Figure Sales Market Share of Neurotherapeutic Drugs by Type (2012-2017) Figure Europe Neurotherapeutic Drugs Sales Growth Rate (%) by Type (2012-2017) Table Europe Neurotherapeutic Drugs Revenue (Million USD) and Market Share (%) Type (2012-2017) Table Europe Neurotherapeutic Drugs Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Neurotherapeutic Drugs by Type (2012-2017) Figure Europe Neurotherapeutic Drugs Revenue Growth Rate by Type (2012-2017) Table Europe Neurotherapeutic Drugs Sales (K Units) and Market Share by Regions (2012-2017) Table Europe Neurotherapeutic Drugs Sales Share by Regions (2012-2017) Figure Sales Market Share of Neurotherapeutic Drugs by Regions (2012-2017) Figure Europe Neurotherapeutic Drugs Sales Market Share by Regions in 2017 Table Europe Neurotherapeutic Drugs Revenue (Million USD) and Market Share by Regions (2012-2017) Table Europe Neurotherapeutic Drugs Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Neurotherapeutic Drugs by Regions (2012-2017) Figure Europe Neurotherapeutic Drugs Revenue Market Share by Regions in 2017 Table Europe Neurotherapeutic Drugs Sales (K Units) and Market Share by Application (2012-2017) Table Europe Neurotherapeutic Drugs Sales Share (%) by Application (2012-2017) Figure Europe Neurotherapeutic Drugs Sales Market Share by Application (2012-2017) Figure Europe Neurotherapeutic Drugs Sales Market Share by Application (2012-2017) Figure Germany Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) (2012-2017) Figure Germany Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Germany Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Germany Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Germany Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Germany Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Germany Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Germany Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Germany Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure UK Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure UK Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure UK Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table UK Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table UK Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure UK Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table UK Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table UK Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure UK Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure France Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure France Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure France Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table France Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table France Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure France Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table France Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table France Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure France Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Russia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Russia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Russia Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Russia Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Russia Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Russia Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Russia Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Russia Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Russia Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Italy Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Italy Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Italy Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Italy Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Italy Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Italy Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Italy Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Italy Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Italy Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Benelux Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Benelux Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Benelux Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Benelux Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Benelux Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Benelux Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Benelux Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Benelux Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Benelux Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Figure Spain Neurotherapeutic Drugs Sales (K Units) and Growth Rate (2012-2017) Figure Spain Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Spain Neurotherapeutic Drugs Sales Price (USD/Unit) Trend (2012-2017) Table Spain Neurotherapeutic Drugs Sales (K Units) by Type (2012-2017) Table Spain Neurotherapeutic Drugs Sales (K Units) Market Share by Type (2012-2017) Figure Spain Neurotherapeutic Drugs Sales (K Units) Market Share by Type in 2017 Table Spain Neurotherapeutic Drugs Sales (K Units) by Applications (2012-2017) Table Spain Neurotherapeutic Drugs Sales (K Units) Market Share by Applications (2012-2017) Figure Spain Neurotherapeutic Drugs Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure Europe Neurotherapeutic Drugs Sales (K Units) and Growth Rate Forecast (2018-2023) Figure Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Europe Neurotherapeutic Drugs Price and Trend Forecast (2018-2023) Table Europe Neurotherapeutic Drugs Sales (K Units) Forecast by Regions (2018-2023) Figure Europe Neurotherapeutic Drugs Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure Europe Neurotherapeutic Drugs Sales (K Units) Market Share Forecast by Regions in 2023 Table Europe Neurotherapeutic Drugs Revenue (Million USD) Forecast by Regions (2018-2023) Figure Europe Neurotherapeutic Drugs Revenue Market Share Forecast by Regions (2018-2023) Figure Europe Neurotherapeutic Drugs Revenue Market Share Forecast by Regions in 2023 Figure Germany Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Germany Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure France Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure France Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure UK Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure UK Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Russia Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Russia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Benelux Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Italy Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Italy Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Spain Neurotherapeutic Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Spain Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table Europe Neurotherapeutic Drugs Sales (K Units) Forecast by Type (2018-2023) Figure Europe Neurotherapeutic Drugs Sales Market Share Forecast by Type (2018-2023) Table Europe Neurotherapeutic Drugs Revenue (Million USD) Forecast by Type (2018-2023) Figure Europe Neurotherapeutic Drugs Revenue Market Share Forecast by Type (2018-2023) Table Europe Neurotherapeutic Drugs Price (USD/Unit) Forecast by Type (2018-2023) Table Europe Neurotherapeutic Drugs Sales (K Units) Forecast by Application (2018-2023) Figure Europe Neurotherapeutic Drugs Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Abbott BD Novartis AG Johnson & Johnson Pfizer Sanofi-Aventis Biogen GlaxoSmithKline AstraZeneca Merck